Health ❯ Obesity ❯ Weight Management

Medications

GLP-1 Receptor Agonists GLP-1 Drugs Semaglutide Tirzepatide GLP-1 Agonists GLP-1 Ozempic Zepbound FDA Approval Patient Access Effects of Weight Loss Medications Anti-Obesity Drugs Eli Lilly Long-term Effects Insurance Coverage Semaglutide Benefits Delivery Services GLP-1 RAs Weight Loss Medications GLP-1 Therapy Orforglipron Oral Treatments Clinical Trials GLP-1 Medicines GLP-1 and Tirzepatide

7 ARTICLES

3mo ago

UCL Review Finds GLP‑1 Drugs Reduce Binge Eating Symptoms

Researchers say large independent long-term trials with routine mental-health screening are needed before using these weight-loss medicines to treat binge eating.

4 ARTICLES

4mo ago

Large Penn Study Finds GLP‑1 Use Tied to Lower Breast Cancer Rates

5 ARTICLES

5mo ago

Shaquille O’Neal Says Zepbound Has Eased His Obstructive Sleep Apnea

9 ARTICLES

8mo ago

Lilly Urges Recall After Finding New Impurity in Compounded Tirzepatide With B12

9 ARTICLES

9mo ago

AstraZeneca Strikes $1.2 Billion CSPC Pact for Once‑Monthly Obesity and Diabetes Programs

5 ARTICLES

11mo ago

Lilly’s Triple-Agonist Retatrutide Shows Major Phase 3 Weight Loss as Grey-Market Use Prompts Warning

3 ARTICLES

last yr.

WeightWatchers Taps Amazon Pharmacy for Faster GLP-1 Access and Delivery

3 ARTICLES

last yr.

Pilot Study Ties GLP-1 Drugs to Slower Alcohol Absorption and Milder Intoxication

8 ARTICLES

last yr.

Costco Adds $499 Ozempic and Wegovy Offer Across U.S. Pharmacies

10 ARTICLES

last yr.

Meta-Analysis Finds Predictable Weight Rebound After Stopping Anti-Obesity Drugs

3 ARTICLES

last yr.

Liraglutide Pilot Study Halves Chronic Migraine Days, Paves Way for Randomized Trials